A股收評:滬指收報2983點 兩市近3700股下跌 風電板塊逆勢走高
A股主要指數今天低開低走,午後延續跌勢,截至收盤滬指跌0.74%報2983點,深證成指跌0.88%,創業板指跌0.88%。兩市近3700股下跌,全天成交7317億元,北上資金淨賣出16.46億元。盤面上,天基互聯、F5G板塊下挫,上海滬工、劍橋信息等跌停;光通信模塊板塊走弱,震有科技跌近15%;芯片股齊跌,同有科技等多股跌超8%;算力概念股走弱,東方國信領跌;CPO概念、星閃概念、鴻蒙概念及通信設備板塊等跌幅居前。另外,超市與大賣場板塊午後拉昇,步步高觸及升停;風電設備板塊維持強勢,大金重工升停;鋰電池板塊走高,恩捷股份、江特機電等多股升停;光伏設備、房地產開發等板塊升幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.